期刊文献+

细胞周期蛋白依赖激酶对肝癌细胞增殖及凋亡的影响 被引量:1

Influences of cyclin dependent kinase on proliferation and apoptosis in hepatic carcinoma cells.
下载PDF
导出
摘要 目的:探讨细胞周期蛋白依赖激酶(cyclin dependent kinase,CDK)对原发性肝癌(肝癌)细胞增殖及凋亡的影响。方法:对体外培养的肝癌细胞株SMMC-7721分别予浓度为0μmol/L、2μmol/L、4μmol/L、8μmol/L、16μmol/L、32μmol/L CDK抑制剂rosco-vitine干预72 h,分别通过倒置显微镜、四甲基偶氮唑蓝法、流式细胞仪、逆转录PCR法观察SMMC-7721细胞的生长、增殖,细胞周期时相的分布、凋亡以及CDK2、半胱氨酸蛋白酶-3和BCL-2 mRNA的表达。结果:予roscovitine干预72 h后,光镜下可见随着roscovitine浓度的增加,部分细胞核固缩、胞体折光性减弱、胞浆内可见有颗粒和核碎片形成,其中以32μmol/L组的改变最为明显。四甲基偶氮唑蓝法结果显示,不同浓度的roscovitine对细胞生长均有一定的抑制作用,roscovitine对细胞的抑制作用呈剂量依赖性和时间依赖性。流式细胞仪检测发现,经roscovitine干预后肝癌细胞G0期、G1期及凋亡细胞的比例增加。逆转录PCR发现,随着roscovitine浓度的增加,CDK2 mRNA及凋亡相关基因BCL-2 mRNA水平降低,半胱氨酸蛋白酶-3 mRNA表达升高。结论:CDK表达降低可抑制增殖期肝癌细胞的增殖,诱导细胞的凋亡,凋亡机制可能与BCL-2、半胱氨酸蛋白酶-3的表达改变有关。CDK在肝癌细胞增殖及凋亡中起着重要作用。 Objective: To explore the influences of cyclin dependent kinase (CDK) on proliferation and apoptosis in hepatic carcinoma cells. Methods: After interfered by roscovitine of 0 μmol/L, 2 μmol/L, 4 μmoL/ L, 8 μmol/L, 16 μmol/L, 32 μmoL/L for 72 hours, inverted microscope, MTT, flow eytometry and reverse transeription-polymerase chain reaction (RT-PCR) were used to observe the effects of CDK on growth, proliferation, cell cycle, apoptosis and the mRNA expression of caspase-3, BCL-2 in SMMC-7721 cells cultured in vitro. Results : After interfered by roseovitine for 72 hours, the microscope showed that a part of nucleus became pyknotic, the eytosome refractivity weakened, particles and nuclear debris appeared in cytoplasm with the increase of roscovitine concentration, and the effect of roscovitine in 32 μmol/L was the most remarkable. The results of MTT also showed that the roseovitine could inhibit the growth of cells with various dose, and the inhibition was dependent on dosage and time. Flow eytometry observed it also could increase the ratio of G0 , G1 and apoptotie cells. RT- PCR showed the mRNA expression of BCL-2 and CDK2 was reduced, and the mRNA expression of caspase-3 was increased by roseovitine. Conclusion: Roscovitine could restrain proliferation and induce apoptosis in hepatic carcinoma cells. The mechanism of apoptosis depends on the activity of BCL-2 and easpase-3. CDK may play an important role on the proliferation and apoptosis in hepatic carcinoma cells.
出处 《新医学》 2009年第5期288-291,F0002,共5页 Journal of New Medicine
基金 江西省教育厅科学技术研究资助项目[赣教技字(2007)096号]
关键词 细胞周期调节蛋白依赖激酶 肝癌 增殖 凋亡 体外试验 Cyclin dependent kinase Hepatic carcinoma Proliferation Apoptosis In vitro study
  • 相关文献

参考文献6

  • 1仲跻巍,李相成.细胞周期调节相关蛋白在肝脏再生中的作用[J].中华肝胆外科杂志,2007,13(7):433-436. 被引量:3
  • 2BETTAYEB K, SALLAM H, FERANDIN Y, et al. N-&- N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine [J]. Mol Cancer Ther, 2008, 7 (9) : 2713-2724.
  • 3LIU L, SCHWARTZ B, TSUBOTA Y, et al. Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration[J]. J Immunol, 2008, 180 (3): 1808-1817.
  • 4STROCK C J, PARK J I, NAKAKURA E K, et al. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells [ J ]. Cancer Res, 2006, 66 (15): 7509-7515.
  • 5CAI D, LATHAM V M J R, ZHANG X, et al. Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells [ J ]. Cancer Res, 2006, 66 (18):9270-9280.
  • 6高建新,刘克敬,周玉琴,张茹华,马雪莲.Roscovitine促进增殖期PC12细胞凋亡[J].基础医学与临床,2005,25(12):1135-1138. 被引量:4

二级参考文献40

  • 1沈金花,张业,吴宁华,沈珝琲.肿瘤抑制剂GA对SH-SY5Y细胞凋亡的影响及分子机制研究[J].基础医学与临床,2004,24(4):380-384. 被引量:2
  • 2Laurent M,Annie B,Odile M,et al.Biochemical and cellular effects of roscovitine,a potent and selective inhibitor of the cyclin- dependent kinesis,cdk2 and cdk5 [J].Eur J Biochem,1997,243:527 - 536.
  • 3Meijer L.Chemical inhibitors of cyclin-dependent kinesis [J].Trends Cell Biol,1996,6:393- 397.
  • 4Azevedo WF,Leclerc S,Meijer L,et al.Inhibition of cyclindependent kinesis by a purine analogs:crystal structure of human cdk2 complexed with roscovitine [J].Eur J Biochem,1997,243:518 - 526.
  • 5Ozuem PM,Jose R,Irma HR.Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB231 breast cancer cells[J].Cancer Research,1999,59:1903- 1910.
  • 6Yakisich JS,Siden A,Vargas Ⅵ,et al.Early inhibition of DNA synthesis in developing rat cerebral cortex by purine analogues olomoucine and roscovitine [J].Biochem Biophys Res Commun,1998,243:674 - 677.
  • 7Hugo C,Mathieu B.Functional diversity of protein phosphates-1,a cellular economizer and reset button:Ⅳ.cell cycle arrest and apoptosis[J].Physiol Rev,2004,84:1 - 39.
  • 8高建新 周玉琴 刘克敬.Caspase—3在roscovitine诱发PC—12细胞调亡中的作用[J].生理通讯,2002,21(1):24-24.
  • 9Nathalie L,Patrick PM,Yves A,et al.The relation between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor [J].Neuroscience letters,2001,297:133 - 136.
  • 10GaoJX ZhouYQ LiuKJ etal.The effects of rosconvitine on proliferating and neuronal differentiated PC—12 cells [J].中国神经科学杂志,2003,19(1):108-108.

共引文献5

同被引文献20

  • 1陈武强,刘胜利,郑杰.RNAi下调hENT_1可增强5-氟尿嘧啶对胰腺癌细胞的毒性[J].中国药科大学学报,2007,38(4):360-364. 被引量:4
  • 2Zhang J, Visser F, King KM, Baldwin SA, Young JD, Cass CE. The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev 2007; 26: 85-110 PubMed DOI.
  • 3Podgorska M, Kocbuch K, Pawelczyk T. Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta Biochim Pol 2005; 52: 749-758 PubMed.
  • 4Procházková A, Liu S, Friess H, Aebi S, Thormann W. Determination of 5-fluorouracil and 5-fluoro-2'-deoxyuridine-5'-monophosphate in pancreatic cancer cell line and other biological materials using capillary electrophoresis. J Chromatogr A 2001; 916: 215-224 PubMed DOI.
  • 5Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 2004; 447: 735-743 PubMed DOI.
  • 6Gray JH, Owen RP, Giacomini KM. The concentrative nucleoside transporter family, SLC28. Pflugers Arch 2004; 447: 728-734 PubMed DOI.
  • 7Kong W, Engel K, Wang J. Mammalian nucleoside transporters. Curr Drug Metab 2004; 5: 63-84 PubMed DOI.
  • 8Visser F, Zhang J, Raborn RT, Baldwin SA, Young JD, Cass CE. Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites. Mol Pharmacol 2005; 67: 1291-1298 PubMed DOI.
  • 9Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, Reinhold WC, Papp A, Weinstein JN, Sadée W. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res 2004; 64: 4294-4301 PubMed DOI.
  • 10Rauchwerger DR, Firby PS, Hedley DW, Moore MJ. Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. Cancer Res 2000; 60: 6075-6079 PubMed.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部